Search - tctmd.com

Displaying 421 - 440 of 962

Sort: Relevancy | Date

News Industry News

Essential Medical Inc. Announces Successful Additional Clinical Studies For MANTA™ Large Bore Vascular Closure Device

May 04, 2015

News Industry News

Pre-Clinical Study Conducted at Mayo Clinic LOS ANGELES, NeuroSigma®, Inc. (NeuroSigma), a California-based life sciences company, today announced that results of an animal study of its Thin Film Nit

May 04, 2015

News Industry News

NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting

May 04, 2015

News Daily News

一项研究了解到了TAVR过程中的脑栓塞形成情况

April 29, 2015

News Daily News

Un Estudio Informa sobre la Embolización Cerebral Durante la Realización de TAVR

April 29, 2015

News Daily News

Study Provides Insight Into Cerebral Embolization During TAVR

April 29, 2015

News Industry News

New Partnership Between St. Jude Medical and Mended Little Hearts Benefits Families of Kids with Congenital Heart Defects

April 27, 2015

News Daily News

El Mejor Grado de Sobredimensionamiento Varía en función del Dispositivo TAVR

Caitlin E. Cox

April 17, 2015

News Daily News

Best Degree of Oversizing Varies by TAVR Device

Caitlin E. Cox

April 17, 2015

News Opinion Fellow Talk

Finding a Job in 5 Steps: Practice Setting Matters

April 16, 2015

News Industry News

Tendyne Announces First Patient Enrolled in US Trans-Catheter Mitral Valve Replacement Trial

April 13, 2015

News Daily News

After Propensity Matching, Early Mortality Risk Still Evident for Transapical TAVR

Todd Neale

April 10, 2015

News Industry News

Medtronic Announces New SPYRAL HTN Global Clinical Trial Program for Renal Denervation

April 01, 2015

News Daily News

PARTNER at 5 Years: TAVR Shows Durable Benefit in Inoperable Patients

March 25, 2015

News Conference News ACC 2015

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

Todd Neale

March 20, 2015

News Conference News ACC 2015

TVT Registry: MitraClip Holds Up Well in Early US Commercial Experience

L.A. McKeown

March 17, 2015

News Conference News ACC 2015

BEST: Due to Less TVR, CABG Still Favored Over PCI in Patients with Multivessel Disease

L.A. McKeown

March 16, 2015

Presentation ACC 2015

Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial

Presenter: Michael J. Mack

March 15, 2015

News Conference News ACC 2015

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

Yael L. Maxwell

March 15, 2015

News Industry News

SAPIEN 3 Valve Demonstrates Low Mortality, Excellent 30-Day Outcomes In High- And Intermediate-Risk Patients

March 15, 2015

Advertisement

Essential Medical Inc. Announces Successful Additional Clinical Studies For MANTA™ Large Bore Vascular Closure Device

Pre-Clinical Study Conducted at Mayo Clinic LOS ANGELES, NeuroSigma®, Inc. (NeuroSigma), a California-based life sciences company, today announced that results of an animal study of its Thin Film Nit

NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting

一项研究了解到了TAVR过程中的脑栓塞形成情况

Un Estudio Informa sobre la Embolización Cerebral Durante la Realización de TAVR

Study Provides Insight Into Cerebral Embolization During TAVR

New Partnership Between St. Jude Medical and Mended Little Hearts Benefits Families of Kids with Congenital Heart Defects

El Mejor Grado de Sobredimensionamiento Varía en función del Dispositivo TAVR

Best Degree of Oversizing Varies by TAVR Device

Finding a Job in 5 Steps: Practice Setting Matters

Tendyne Announces First Patient Enrolled in US Trans-Catheter Mitral Valve Replacement Trial

After Propensity Matching, Early Mortality Risk Still Evident for Transapical TAVR

Medtronic Announces New SPYRAL HTN Global Clinical Trial Program for Renal Denervation

PARTNER at 5 Years: TAVR Shows Durable Benefit in Inoperable Patients

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

TVT Registry: MitraClip Holds Up Well in Early US Commercial Experience

BEST: Due to Less TVR, CABG Still Favored Over PCI in Patients with Multivessel Disease

Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

SAPIEN 3 Valve Demonstrates Low Mortality, Excellent 30-Day Outcomes In High- And Intermediate-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content